Page 69 - Orphan News Today

19 children have been living in freezing cellars hiding from shelling in harrowing conditions

Salt Lake City, Utah--(Newsfile Corp. - March 18, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") has received Orphan Drug Designation from the U.S. Food and Drug Administration

STOCKHOLM, March 18, 2022 /PRNewswire/ -- Sobi today announced that the National Medical Products Administration of China (NMPA) has approved Gamifant (emapalumab) for use in China. The indication

The cub was found crying by a passerby and was taken in by wildlife officials before being introduced to a new family.

This follows the previously granted ODD for polihexanide in Acanthamoeba Keratitis by the FDA and EMA. An estimated 15,660 patients with fungal keratitis are diagnosed annually in the

(PLX AI) - Genmab Announces U.S. Food and Drug Administration Granted Orphan-Drug Designation to Epcoritamab (DuoBody-CD3xCD20) in Follicular Lymphoma.• Epcoritamab is being co-developed by Genmab and

COVID-19 has spurred many problems. Among them: local agencies that work with children report an uptick in substance misuse by parents since the start of the...

- Mocravimod is being developed as a potential best-in-class adjunctive and maintenance therapy to enhance the curative potential of HSCT for AML patients - A global registration-enabling

The Breckenridge family has been in the process of adopting 15-year-old Artem.

Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the expansion of its Scientific Advisory